Medicare Enrolled

Dr. Do-Eun Lee, MD

Endocrinology · Napa, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3434 VILLA LN, Napa, CA 94558
7072596767
In practice since 2006 (19 years)
NPI: 1346339652 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lee

Dr. Do-Eun Lee is an endocrinology specialist in Napa, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 16,530 Medicare services across 1,627 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lee received a total of $90,535 from 57 pharmaceutical and/or device companies across 1286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in CA $90,535 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,530
Medicare services
Top 6% in CA for endocrinology
1,627
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~870 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Romosozumab injection (Evenity) for osteoporosis 9,240 $8 $20
Denosumab injection (Prolia/Xgeva) 4,382 $18 $40
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
1,127 $55 $210
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
727 $110 $302
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
325 $76 $280
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
208 $132 $400
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
129 $13 $45
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
126 $108 $317
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
119 $28 $119
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
42 $48 $200
New patient office visit, complex (60-74 min) 32 $183 $574
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
28 $140 $287
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
27 $100 $480
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
18 $59 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$90,535
Total received (2018-2024)
Avg $12,934/year across 7 years
Top 5% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53,957 (59.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,666 (21.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,912 (18.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,069
2023
$22,087
2022
$4,928
2021
$3,428
2020
$6,431
2019
$11,965
2018
$30,627

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$8,865
Lilly USA, LLC
$656
Antares Pharma, Inc.
$223
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
Novo Nordisk Inc
$194
Corcept Therapeutics
$146
Alexion Pharmaceuticals, Inc.
$135
Bayer Healthcare Pharmaceuticals Inc.
$122
AstraZeneca Pharmaceuticals LP
$114
Xeris Pharmaceuticals, Inc.
$69
IBSA Pharma Inc.
$60
Radius Health, Inc.
$56
BETA BIONICS, INC.
$50
Astellas Pharma US Inc
$50
SANOFI-AVENTIS U.S. LLC
$36
ABBVIE INC.
$27
Daiichi Sankyo Inc.
$24
GENZYME CORPORATION
$24
Nevro Corp.
$14
Top 3 companies account for 88.0% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$20,585
Janssen Pharmaceuticals, Inc
$17,760
SANOFI-AVENTIS U.S. LLC
$11,844
Amgen Inc.
$9,941
Corcept Therapeutics
$8,199
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,722
Lilly USA, LLC
$3,523
Novo Nordisk Inc
$2,873
AstraZeneca Pharmaceuticals LP
$1,766
Insulet Corporation
$1,293
Radius Health, Inc.
$1,272
Alexion Pharmaceuticals, Inc.
$530
Abbott Laboratories
$488
Mannkind Corporation
$366
Shire North American Group Inc
$365
Bayer Healthcare Pharmaceuticals Inc.
$322
MannKind Corporation
$311
Amarin Pharma Inc.
$309
Antares Pharma, Inc.
$307
Medtronic MiniMed, Inc.
$290
Amneal Pharmaceuticals LLC
$225
ASCEND Therapeutics US, LLC
$167
Merck Sharp & Dohme Corporation
$162
Medtronic, Inc.
$158
IBSA Pharma Inc.
$154
Xeris Pharmaceuticals, Inc.
$132
Janssen Scientific Affairs, LLC
$120
AbbVie Inc.
$113
Biohaven Pharmaceutical Holding Company Ltd.
$85
Nalpropion Pharmaceuticals LLC
$85
Currax Pharmaceuticals LLC
$83
Echosens North America, Inc.
$82
Tandem Diabetes Care, Inc.
$77
Regeneron Healthcare Solutions, Inc.
$74
Dexcom, Inc.
$59
RECORDATI_RARE_DISEASES_INC.
$56
ASCEND THERAPEUTICS US, LLC
$52
BETA BIONICS, INC.
$50
Astellas Pharma US Inc
$50
Bayer HealthCare Pharmaceuticals Inc.
$49
Biohaven Pharmaceuticals, Inc.
$46
ABBVIE INC.
$43
Zealand Pharma US, Inc.
$43
Embecta Corp.
$39
Ascendis Pharma Inc
$29
RGH Enterprises LLC
$24
Daiichi Sankyo Inc.
$24
GENZYME CORPORATION
$24
Companion Medical, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Esperion Therapeutics, Inc.
$21
Supernus Pharmaceuticals, Inc.
$21
Eisai Inc.
$20
Orexigen Therapeutics, Inc.
$16
Nevro Corp.
$14
Intuity Medical Inc
$13
Top 3 companies account for 55.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APIDRA · BAQSIMI · BD Nano 2nd Gen Pen Needle · BINOSTO · BYDUREON · CONTRAVE · Dayvigo · Dexcom G6 Transmitter · ENHERTU · ESTROGEL · EVENITY · FABRAZYME · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · Guardian Connect · HUMULIN · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · LYUMJEV · MINIMED 770G · MOUNJARO · Macrilen · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NURTEC ODT · Norditropin · NovoLog · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · Prolia · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Strensiq · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for endocrinology in CA.

Looking for an endocrinology specialist in Napa?
Compare endocrinologists in the Napa area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
14
Per 100K population
10.3
County median income
$108,970
Nearest hospital
PROVIDENCE QUEEN OF THE VALLEY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lee is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with speaking/promotional industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lee experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Lee performed 9,240 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $90,535 from 57 companies across 1,286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other endocrinologists in Napa?
Dr. Lee's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →